HomeNewsBusinessStocksCadila Healthcare may test Rs 250-260: Ashwani Gujral

Cadila Healthcare may test Rs 250-260: Ashwani Gujral

Ashwani Gujral of ashwanigujral.com is of the view that Cadila Healthcare may test Rs 250-260.

March 23, 2016 / 15:43 IST
Story continues below Advertisement

Your browser doesn't support HTML5 video.

Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "Cadila Healthcare had a breakdown yesterday but I don't think that is reflected in the rest of the pharma space. Overall I think we should look for levels of Rs 250-260 the way it has broken down. However at best it can be ignored because of too much news flow. I think other stocks like Strides Shasun or Wockhardt, even Ajanta Pharma are much better midcap stocks."Cadila Healthcare closed at Rs 320.80, down Rs 2.40, or 0.74 percent. It has touched an intraday high of Rs 328.30 and an intraday low of Rs 313.60.

first published: Mar 23, 2016 03:43 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!